Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-060218

Chief Accounting Officer & VP gave up 1,640 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Monohon Ted · Chief Accounting Officer & VP

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-05 Shares withheld for taxes : show line 1 in the form −1,640 $0.72 $1,181 29,311 D
Loading xslF345X03/doc4.xml…